We also demonstrate the inhibitory effect of ATP2B3 knockdown on the P62−KEAP1−NRF2−HO-1 signaling pathway, which has potential implications for the treatment of neurological diseases. This evidence concerns the gene ATP2B3 and nervous system disorder.